Amgen (AMGN) PT Raised to $263 at Truist Securities, Company is "De-risked of Binary Events"
Tweet Send to a Friend
Truist Securities analyst Robyn Karnauskas raised the price target on Amgen (NASDAQ: AMGN) to $263.00 (from $255.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
